X4 Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Great morning, everybody. Thanks for joining us for day three. I'm Matthew Harrison with investment banking here at Morgan Stanley. Pleased to have X4 with us for the first fireside today.
Just quickly before we get started, I have to read a disclosure statement. Please note that all important disclosures can be found at morganstanley.com/researchdisclosures.
Questions & Answers
Paula and Adam, thanks for being here. Appreciate it. I thought maybe why don't we just start out a little bit with -- obviously you're developing an asset for a variety of neutropenic conditions. Maybe you could just talk a little bit about where the drug came from, what's the mechanism, and sort of how you've decided on the indications you're going after.
Yeah. Thank you, Matthew. Thanks so much for having us here at the conference. We're really excited about X4. The company
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |